Related Experiment Videos
Salvage Robotic-assisted Laparoscopic Radical Prostatectomy: Experience with 14 Cases
Yen-Chuan Ou1,2,3, Sheng-Chun Hung4,3, Li-Hua Hwang5
1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C. ycou228@gmail.com.
Anticancer Research
|April 5, 2017
Summary
Salvage robot-assisted radical prostatectomy (S-RaRP) is a feasible procedure for recurrent prostate cancer. This study shows encouraging short-term oncological outcomes, including good continence rates and low complication rates.
Area of Science:
- Urology
- Oncology
- Robotic Surgery
Background:
- Recurrent prostate cancer after initial treatment poses a clinical challenge.
- Salvage therapies aim to improve outcomes for patients with rising PSA levels.
- Robot-assisted radical prostatectomy (S-RaRP) is an option for selected patients.
Purpose of the Study:
- To evaluate the outcomes of salvage robot-assisted radical prostatectomy (S-RaRP).
- To assess the feasibility, complication rates, and oncological control of S-RaRP.
Main Methods:
- Retrospective analysis of 14 patients who underwent S-RaRP.
- Patients had prior definitive treatment including external irradiation, cyberknife, or high-intensity focused ultrasound.
- Data collected included pre-operative PSA, Gleason score, and time to S-RaRP.
Main Results:
- A total of 14 patients underwent S-RaRP with a mean follow-up of 32.4 months.
- The positive surgical margin rate was 21.4%, with a continence rate of 71.4%.
- Biochemical recurrence-free survival was observed in 78.5% of patients.
Conclusions:
- S-RaRP is a feasible surgical option for recurrent prostate cancer.
- The procedure demonstrates a low complication rate and favorable short-term oncological control.
- Good functional outcomes, including urinary continence, were reported.